5-HT2C agonism as a neurotherapeutic for sarcopenia: preclinical proof of concept

Nathan R. Kerr, Anna R. Dashtmian, Fereshteh B. Darvishi, Charles D. Brennan, Sindhuja N. Ayyagari, Peter J. Moore, Jose A. Viteri, Meifang Wang, Mark M. Rich, Brian C. Clark, W. David Arnold

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalGeroScience
DOIs
StateAccepted/In press - 2025
Externally publishedYes

ASJC Scopus Subject Areas

  • Aging
  • veterinary (miscalleneous)
  • Complementary and alternative medicine
  • Geriatrics and Gerontology
  • Cardiology and Cardiovascular Medicine

Keywords

  • 5-HT receptor agonism
  • Age-related muscle weakness
  • Lorcaserin
  • Motor neuron excitability
  • Neurotherapeutics
  • Sarcopenia

Cite this